Metro Healthcare Indonesia Tbk. vs Mandiri Herindo Adiperkasa Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 109K 24h volume), while Mandiri Herindo Adiperkasa Tbk. trades at Rp141 (market cap 2.33T, 1.51M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 6.1× Mandiri Herindo Adiperkasa Tbk.'s market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (1.51M versus 109K). Which is the better fit depends on your goals.
| CARE | MAHA | |
|---|---|---|
Market Cap | 14.23T | 2.33T |
Volume | 109K | 1.51M |
Lot | 1.09K | 15.06K |
Turnover | 46.56M | 211.02M |
Average Price | 427.15 | 140.16 |
Value | 46.56M | 211.02M |
Indicative Equilibrium Price | 428 | 142 |
Indicative Equilibrium Volume | 400 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →